Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
The discovery of GLP-1 and its role in regulating blood glucose was a major scientific breakthrough in diabetes research, yet turning this peptide hormone into an effective medication was no easy task
This theory posits that excessive wantinga heightened motivational drive triggered by reward-related cuesunderlies addictive behaviors, distinct from the hedonic liking of drugs
POTENT NUTRIENT BLEND: Enriched with resveratrol, maca root, ashwagandha, and antioxidant-rich botanicals (cranberry, blueberry, acai, pomegranate, beet root) to help combat oxidative stress
This video breaks down how tirzepatide, a first-in-class dual incretin receptor agonist, targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors to improve metabolic outcomes
The study also discovered the roles of 1-adrenergic and - and -opioid receptors in this process
